Benefits of Diane 35 and generics outweigh risks in specific patient group

View source ↗

Summary

EMA indicates that the benefits of Diane-35 and its generics outweigh the risks for a defined group of patients, with specific considerations to use and monitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne
• Androgen-related Conditions
• Polycystic Ovary Syndrome

Drugs mentioned

• Diane-35 (ethinylestradiol / cyproterone acetate)